b 859 (Flecainide 50 mg)
Pill imprint b 859 has been identified as Flecainide acetate 50 mg.
Flecainide is used in the treatment of atrial fibrillation; atrial flutter; paroxysmal supraventricular tachycardia; supraventricular tachycardia; ventricular tachycardia (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 50 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 50 mg
- 7.00 mm
- Prescription only
sodium stearyl fumarate
More about flecainide
- Other brands: Tambocor
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.